Skip to main content

Negligence in Prolift Design Cost J&J & Ethicon $35 Million

Negligence in Prolift Design Cost J&J & Ethicon $35 Million

Negligence in Prolift Design Cost J&J & Ethicon $35 Million

Introduction

A nine-person jury panel held J&J and its Ethicon Inc. subsidiary responsible for being negligent in designing and marketing of Prolift, a transvaginal mesh device, which caused chronic pelvic pain since the time the plaintiff underwent a prolapse repair surgery in 2009. The jury pointed that the defendants marketed, sold, and recruited physicians worldwide to implant the mesh implant device for Pelvic Floor Repair in women that suffered from pelvic prolapse. The plaintiff was awarded $10 million as compensatory and $25 million as punitive damages in the U.S. District Court for the Northern District of Indiana Judiciary, with Honorable Judge Philip P. Simon presiding over the 9-day trial.

Over 55,000 product liability claims involving Prolift and other transvaginal mesh implants are a part of the centralized litigation in the U.S. District Court for the Southern District of West Virginia.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

Talcum Powder Cancer Settlement Talks Begin Sept. 4

Categories: Talcum

Representatives of Johnson & Johnson (J&J) and attorneys for tens of thousands of plaintiffs involved in talcum powder lawsuits are scheduled to meet in September 2025 in an…

Tepezza Hearing Loss Trials Delayed Until Aug 2026

Categories: Tepezza

A series of Tepezza hearing loss lawsuits, which were expected to go before juries next year, will now be delayed. The U.S. District Judge overseeing the multidistrict…

Cencora Directors Settle Opioid Oversight Case for $111M

Categories: Opioids

Cencora has agreed to pay $111.3 million to settle a shareholder lawsuit accusing the company’s directors of failing to prevent the unlawful distribution of opioids

✍️ 100% FREE — 60 mins Legal Transcription and 2 Demand Letters!                 
🔒 No AI. No Risk. No Contract. 100% HIPAA-Compliant, Done by Attorneys & Doctors.

Only 06 Slots left for Law Firms—Offer Ends Sep 30!